Great claims indeed. The way I understand it, Chinese Pharma are...

Great claims indeed. The way I understand it, Chinese Pharma are actually incentivised to do a licensing deal with a forgein company. They can piggyback the results of our P3 trial by just doing or ensuring that a subset (10% I think) of the trial are ethnic chinese. Huge incentive to sign up. The upfront and milestones to PAR for a license would cost way less, and get them to market way quicker than, finding a non-bene supplier, starting trials from GMP, P1, P2, P3, fighting patent infringements and so on etc... What I'm not clear on is whether a partner would do a small trial in China as part of the deal, or PAR ensure a 10% chinese subset in the existing P3? Either way I note the last bullet that registration in China can happen before registration anywhere else, another derisker for a potential Chinese partner.